6505--Radiopharmaceuticals Base Plus 4 Option Year IDIQ
ID: 36C24525Q0234Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF245-NETWORK CONTRACT OFFICE 5 (36C245)LINTHICUM, MD, 21090, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/33b149d3b2f2431694961e37e8a212bb/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the procurement of radiopharmaceuticals, specifically Tc99m-derived products and related compounds, to be delivered to the Veterans Affairs Martinsburg Medical Center. The contract will commence on April 1, 2025, and includes a base year with four optional one-year extensions, concluding on March 31, 2030. These radiopharmaceuticals are critical for medical and diagnostic purposes within federal healthcare facilities, necessitating reliable delivery and compliance with strict safety and regulatory standards. Interested vendors must ensure they can meet the requirements for immediate orders, maintain quality control, and adhere to health regulations, with inquiries due by February 21, 2025, and responses by February 28, 2025. For further information, contact Contracting Officer Kami Hom at Kami.Hom@va.gov or by phone at 410-642-2411 x22404.

    Point(s) of Contact
    Kami HomContracting Officer
    410-642-2411 x22404
    Kami.Hom@va.gov
    Files
    Title
    Posted
    36C24525Q0234_1.docx
    The Combined Synopsis/Solicitation Notice seeks proposals for the procurement of radiopharmaceuticals through an Indefinite Delivery Indefinite Quantity (IDIQ) contract with the Department of Veterans Affairs (VA). The contract spans a base year starting April 1, 2025, with four one-year option years, concluding March 31, 2030. The contractor must deliver specified radiopharmaceuticals to the Veterans Affairs Martinsburg Medical Center, providing at least three daily deliveries while adhering to strict safety and regulatory standards. Key requirements include proper licensing, capability for immediate orders within two hours, and experience in radiopharmacy services. The contractor is obligated to maintain quality control and comply with health regulations, including FDA and USNRC guidelines. The document details the required products, services, and delivery schedules, emphasizing reliability and performance standards. The timeline for inquiries and submissions is specified, including deadlines for questions by February 21, 2025, and responses by February 28, 2025. This solicitation underscores the VA’s commitment to ensuring high-quality medical services for veterans, emphasizing accountability, efficiency, and compliance throughout the procurement process.
    36C24525Q0234 LineItems.xlsx
    The document outlines a Request for Quotation (RFQ) from the federal government for the provision of various radiopharmaceuticals, specifically Tc99m-derived products and related compounds. It provides itemized details for 17 major products, including specific forms and dosages like Tc99m Sestamibi and F18 FDG, with specified quantities ranging from 1 to 2400 units for each item, all priced at mentioned rates. The contract spans from April 1, 2025, to March 31, 2026, with potential extensions through options for additional yearly periods up to 2030. Each item is designated with a unit of measure (each, EA) and is marked as non-discounted, suggesting standard pricing without rebates. The extensive inventory indicates that supplies will be critical for medical and diagnostic purposes in federal healthcare facilities. Overall, this RFQ exemplifies the government’s needs for ongoing medical substance procurement and compliance with federal contracting protocols for health-related supplies.
    Lifecycle
    Title
    Type
    6505--Radiopharmaceuticals Base Plus 4 Option Year IDIQ
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--NEW IDIQ - NON Cyclotron Radiopharmaceuticals For time period covering FY 2025 through FY 2030
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to provide NON-Positron Emission Tomography (PET) Radiopharmaceuticals through a new Indefinite Delivery Indefinite Quantity (IDIQ) contract for the period covering Fiscal Years 2025 through 2030. The procurement aims to secure reliable and compliant supplies of prepared single doses of radiopharmaceuticals, adhering to strict quality and regulatory standards, with an emphasis on promoting small business participation in federal procurement. These radiopharmaceuticals are critical for supporting the healthcare services provided by the VA, ensuring timely delivery and compliance with safety regulations. Interested parties should contact Contract Specialist Edward Hunter at edward.hunter@va.gov for further details regarding the solicitation and requirements.
    6505--Radiopharmaceutical Delivery for VASNHCS Single Award IDIQ
    Buyer not available
    The Department of Veterans Affairs is preparing to solicit proposals for a contract titled "6505--Radiopharmaceutical Delivery for VASNHCS," aimed at providing radiopharmaceuticals to the VA Southern Nevada Healthcare System. This procurement is essential for ensuring the timely delivery of critical medical supplies necessary for patient care and treatment within the healthcare system. The solicitation is expected to be released around February 6, 2025, with quotes due by February 21, 2025, and the contract will be awarded on an unrestricted basis, allowing all responsible sources to participate. Interested contractors can reach out to Contract Specialist Mohammed Hussain at Mohammed.Hussain2@va.gov or by phone at 916-923-4534 for further information.
    6505--Radiopharmaceuticals
    Buyer not available
    The Department of Veterans Affairs is seeking qualified contractors to provide radiopharmaceuticals for the Portland, OR VA Medical Center, as outlined in a Sources Sought Notice. The procurement aims to identify vendors capable of supplying a range of nuclear medicine agents, including but not limited to Technetium-99m and I-131 Sodium Iodide, with requirements for timely ordering and delivery, including same-day service for urgent requests. These radiopharmaceuticals are critical for diagnostic imaging and patient care, ensuring that the VA healthcare services can effectively meet the needs of veterans. Interested parties should contact José Ronstadt at jose.ronstadt@va.gov or call 360-852-9885 for further details, with the anticipated period of performance running from July 1, 2025, to June 30, 2030.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the supply of radiopharmaceuticals to the Naval Medical Center Portsmouth. The procurement aims to secure a range of unit dose radiopharmaceuticals essential for cancer patient care, including isotopes such as Tc-99m, I-123, and F-18, with specific quantities and pricing outlined for various medical applications over multiple contract periods from 2026 to 2030. These radiopharmaceuticals play a critical role in diagnostic imaging and treatment, ensuring that healthcare providers have access to necessary medical supplies for effective patient care. Proposals are due by March 11, 2025, with inquiries accepted until February 17, 2025; interested vendors should contact Carol Uebelacker at carol.e.uebelacker.civ@health.mil or call 210-952-8111 for further details.
    6505--NEW IDIQ - NON-PET Radiopharmaceuticals For Ordering periods from FY25 through FY29
    Buyer not available
    The Department of Veterans Affairs is preparing to issue a Request for Quote (RFQ) for NON-Positron Emission Tomography (PET) Radiopharmaceuticals intended for the VA Palo Alto Healthcare System. This procurement will cover ordering periods from Fiscal Year 2025 through Fiscal Year 2029 and is categorized under NAICS code 325412, emphasizing the importance of specialized radiopharmaceuticals in providing healthcare services to veteran patients. The RFQ is an open market solicitation aimed at awarding a single firm-fixed price contract, with solicitation documents expected to be available around February 14, 2025, and responses due by 12:00 PM Pacific Time on February 28, 2025. Interested parties can direct inquiries to Contracting Officer Edward Hunter at edward.hunter@va.gov or by phone at (702) 791-9000.
    6505--Ga68 NETSPOT Radiopharmaceuticals Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of NETSPOT Ga68 radiopharmaceuticals for the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, PA. This procurement involves a firm-fixed-price contract for a 12-month period, commencing on June 4, 2025, and concluding on June 3, 2026, with a focus on supplying essential radiopharmaceuticals for imaging neuroendocrine tumors in adult patients. The selected vendor must be licensed by the Nuclear Regulatory Commission and adhere to strict delivery and regulatory standards, ensuring timely and compliant service. Interested vendors must submit their proposals by 10:00 AM EST on February 27, 2025, and can direct inquiries to Contract Specialist Christa Stine at christa.stine@va.gov or by phone at 570-824-3521.
    6505--Radiopharmaceutical Isotopes (Cardiology) Sources Sought
    Buyer not available
    The Department of Veterans Affairs is seeking potential contractors to supply radiopharmaceutical isotopes for the Nuclear Cardiology Lab at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. The procurement aims to identify vendors capable of providing specific isotopes along with related services, including next-day delivery and quality control testing, while ensuring compliance with DOT regulations for transporting radioactive materials. These isotopes are critical for patient diagnostics in cardiology, underscoring the importance of reliable and timely supply. Interested parties must respond by February 20, 2025, and can direct inquiries to Contracting Officer Stacy Massey at Stacy.Massey@va.gov or by phone at 414-844-8400.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire high-tech medical imaging equipment, specifically targeting the needs of the National Acquisition Center (NAC) for various healthcare facilities serving veterans. The procurement process is crucial for enhancing healthcare services, ensuring that the VA can provide state-of-the-art diagnostic and treatment capabilities. Key deadlines include the submission of vendor questions by February 19, 2025, and the final offer submission due by April 9, 2025. Interested vendors should direct inquiries to Contract Specialist Hermann A. Degbegni at hermann.degbegni@va.gov for further details.
    F108--Pharmaceutical Waste Removal | MA (VA-25-00001921)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on pharmaceutical waste removal services at the Marion VA Medical Center and Evansville Health Care Center. The contract, valued at an estimated $47 million, is set aside exclusively for service-disabled veteran-owned small businesses and will encompass the collection and disposal of hazardous, non-hazardous, chemical, universal, and DEA drug waste, adhering to all relevant federal, state, and local regulations. This initiative underscores the importance of safe and compliant waste management practices within VA facilities, ensuring public safety and environmental protection. Interested vendors must submit their pricing and demonstrate the necessary qualifications by contacting Contract Specialist Lisa A Buchanan at Lisa.Buchanan1@va.gov, with the contract expected to commence in 2025.